Literature DB >> 31545225

Ardisia crispa root hexane fraction suppressed angiogenesis in human umbilical vein endothelial cells (HUVECs) and in vivo zebrafish embryo model.

Lim Wen Jun1, Chan Pit Foong1, Roslida Abd Hamid2.   

Abstract

Ardisia crispa Thunb. A. DC. (Primulaceae) has been used extensively as folk-lore medicine in South East Asia including China and Japan to treat various inflammatory related diseases. Ardisia crispa root hexane fraction (ACRH) has been thoroughly studied by our group and it has been shown to exhibit anti-inflammatory, anti-hyperalgesic, anti-arthritic, anti-ulcer, chemoprevention and suppression against inflammation-induced angiogenesis in various animal model. Nevertheless, its effect against human endothelial cells in vitro has not been reported yet. Hence, the aim of the study is to investigate the potential antiangiogenic property of ACRH in human umbilical vein endothelial cells (HUVECs) and zebrafish embryo model. ACRH was separated from the crude ethanolic extract of the plant's root in prior to experimental studies. MTT assay revealed that ACRH exerted a concentration-dependent antiproliferative effect on HUVEC with the IC50 of 2.49 ± 0.04 μg/mL. At higher concentration (10 μg/mL), apoptosis was induced without affecting the cell cycle distribution. Angiogenic properties including migration, invasion and differentiation of HUVECs, evaluated via wound healing, trans-well invasion and tube formation assay respectively, were significantly suppressed by ACRH in a concentration-dependent manner. Noteworthily, significant antiangiogenic effects were observed even at the lowest concentration used (0.1 μg/mL). Expression of proMMP-2, vascular endothelial growth factor (VEGF)-C, VEGF-D, Angiopoietin-2, fibroblast growth factor (FGF)-1, FGF-2, Follistatin, and hepatocyte growth factor (HGF) were significantly reduced in various degrees by ACRH. The ISV formation in zebrafish embryo was significantly suppressed by ACRH at the concentration of 5 μg/mL. These findings revealed the potential of ACRH as antiangiogenic agent by suppressing multiple proangiogenic proteins. Thus, it can be further verified via the transcription of these proteins from their respective DNA, in elucidating their exact pathways.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Angiogenesis inhibitor; Ardisia crispa; Cell migration assay; HUVECs; VEGF

Mesh:

Substances:

Year:  2019        PMID: 31545225     DOI: 10.1016/j.biopha.2019.109221

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Cytotoxic 13,28 Epoxy Bridged Oleanane-Type Triterpenoid Saponins from the Roots of Ardisia crispa.

Authors:  Xin Yin; Ruihang Hu; Yongqiang Zhou; Weiqian Zhu; Ying Zhou
Journal:  Molecules       Date:  2022-02-04       Impact factor: 4.411

2.  Integrated transcriptome and metabolome analyses revealed regulatory mechanisms of flavonoid biosynthesis in Radix Ardisia.

Authors:  Chang Liu; Jie Pan; Zhi-Gang Yin; Tingting Feng; Jiehong Zhao; Xiu Dong; Ying Zhou
Journal:  PeerJ       Date:  2022-06-29       Impact factor: 3.061

3.  Quinone-rich fraction of Ardisia crispa (Thunb.) A. DC roots alters angiogenic cascade in collagen-induced arthritis.

Authors:  Joan Anak Blin; Razana Mohd Ali; Armania Nurdin; Roslida Abd Hamid
Journal:  Inflammopharmacology       Date:  2021-06-05       Impact factor: 4.473

4.  Cytotoxic Evaluation and Anti-Angiogenic Effects of Two Furano-Sesquiterpenoids from Commiphora myrrh Resin.

Authors:  Ali S Alqahtani; Fahd A Nasr; Omar M Noman; Muhammad Farooq; Tariq Alhawassi; Wajhul Qamar; Ali El-Gamal
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

5.  Bioactive fractions and compound of Ardisia crispa roots exhibit anti-arthritic properties mediated via angiogenesis inhibition in vitro.

Authors:  Joan Anak Blin; Roslida Abdul Hamid; Huzwah Khaza'ai
Journal:  BMC Complement Med Ther       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.